Buy or sell Cleerly stock pre IPO via an EquityZen fund
Heart Disease Diagnosis Solutions
About Cleerly Stock
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
Cleerly is headquartered in New York, NY, and was founded in 2017. Notable investors include Fidelity Management and Research, Novartis, and T. Rowe Price.
Fidelity Management and Research
Fidelity Management and Research Company
General Catalyst Partners
New Leaf Venture Partners
Sands Capital Ventures
T. Rowe Price
Chief Executive Officer
Chief Medical Officer
builtinnyc - Jul, 26 2022
vator - Jul, 1 2021
TechCrunch - Jun, 23 2021